APPROVAL OF NIH RESEARCH PROJECT ENTITLED "TARGETED

UNCLAS BRASILIA 002458 SIPDIS SIPDIS STATE PASS TO DHHS/NIH/FIC FOR KEVIN BIALY E.O. 12958: N/A TAGS: TBIO KSCA OSCI BR SUBJECT: APPROVAL OF NIH RESEARCH PROJECT ENTITLED "TARGETED THERAPHY FOR BURKITT LYMPHOMA IN RESOURCE POOR SETTING" REF: BRASILIA 1880 ¶1. On November 16, 2006, Embassy received from the Brazilian Ministry of Foreign Affairs, Division of Science and Technology (DCTEC/MFA) an official notification (number 56, dated November 16, 2006) approving the research project proposal titled "Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings", (number CA 121935-01),under the direction of Dr. Carlos Brites Alves, Dr. Jose Henrique Silva Barreto, Dr. Iguaracyra Barreto de Oliveira Araujo, from the Federal University of Bahia. Informal translation of the approval notice follows: Begin text: "This is to inform that after consultation to the appropriate federal organs, the project titled "Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings," to be developed by the principal investigator Dr. Carlos Roberto Brites Alves, from the Universidade Federal da Bahia (UFBA),Dr. Jose Henrique Silva Barreto and Dr. Iguaracyra Barreto de Oliveira Araujo, these last two only considered as investigators, financially supported by the National Institutes of Health (NIH),was approved by the Brazilian Government. 2) I emphasize that for the collection and transfer of data and/or biological material abroad, procedures should conform to current legislation. Cordially, (signature) Everton Frask Lucero Head of the Division of Science and Technology" End of text of translation. ¶2. The Embassy sees no adverse foreign policy implications with respect to this research project. We reiterate the importance of complying with Brazilian law on the export of data and biological material and medical research involving human beings. CHICOLA